NCT04290949

Brief Summary

To assess the platelet indices in patients undergoing primary percutaneous coronary intervention and its relation to the severity of coronary artery disease and short term clinical outcomes

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 20, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 2, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

March 2, 2020

Status Verified

February 1, 2020

Enrollment Period

1.6 years

First QC Date

September 30, 2019

Last Update Submit

February 27, 2020

Conditions

Acute Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • the severity of coronary artery disease and short term clinical outcomes

    Platelet indices as mean Platelet Volume (MPV)in femtoliter , platelet distribution width (PDW) (FL)% and (PCT)% May be larger and could be a risk of Stratification in patients undergoing primary percutaneous coronary intervention

    follow up patients 6 monthes

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

100 patients presented with acute myocardial infarction who undergoing primary percutaneous intervention

You may qualify if:

  • Adult patients (age ≥ 18 years) that presented with acute ST elevation myocardial infarction

You may not qualify if:

  • Cardiomyopathy,
  • Previous revascularization procedure
  • Any history of bleeding diathesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Alaa El din Abd El Moniem, Professor

    Critical Care Unit, Internal Medicine Department

    STUDY DIRECTOR

Central Study Contacts

Ishraq Hassan, Physician

CONTACT

+201065967424Ishraqhosny@gmail.com

Ahmed Thabet, Lecturer

CONTACT

+201061461306drahmedfarag2005@yahoo.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Critical Care Unit, Internal Medicine Department

Study Record Dates

First Submitted

September 30, 2019

First Posted

March 2, 2020

Study Start

February 20, 2020

Primary Completion

October 1, 2021

Study Completion

December 1, 2021

Last Updated

March 2, 2020

Record last verified: 2020-02